Categories AlphaGraphs, Earnings

AngioDynamics misses Q3 revenue expectation; reports double digit earnings growth

Medical device manufacturer AngioDynamics’ (ANGO) third quarter 2018 revenue fell short of consensus estimate. The company’s revenue dropped 2.1% year-over-year, while the US tax reform lifted the reported earnings and per share figures, which more than tripled for the quarter. The revenue miss was mainly due to the declines in the Venous Insufficiency business and a negative year-over-year comparison related to the Radiofrequency Ablation (RFA) product line that was discontinued in Japan. Profit jumped to $14 million or $0.37 per share from the year ago profit of $2.9 million or $0.08 per share. On an adjusted basis, earnings spiked 31.5% to $0.25 per share.

Geographically, US net sales fell short of expectations, declining 2.8%, hurt by declining sales of Venous, PICCs, and RFA businesses. However, international sales experienced a positive growth due to consistent performance across all the business units.

Outlook

AngioDynamics reaffirmed its financial guidance for fiscal year 2018 and expects net sales in the range of $345 million to $350 million. Adjusted EPS is expected in the range of $0.64 to $0.68, excluding any impact from the 2017 Tax Reform Act. Including the impact of Tax Reform, adjusted EPS is eyed in the range of $0.70 to $0.74.

AngioDynamics earnings
AngioDynamics Q3 Earnings Snapshot

Most Popular

V Earnings: Key quarterly highlights from Visa’s Q1 2023 financial results

Visa Inc. (NYSE: V) reported first quarter 2023 earnings results today. Net revenues grew 12% year-over-year to $7.9 billion. GAAP net income rose 6% to $4.2 billion while EPS grew

Earnings: Highlights of Intel’s (INTC) Q4 2022 financial results

Intel Corporation (NASDAQ: INTC) Thursday reported a decline in adjusted earnings and revenues for the fourth quarter. The semiconductor giant also provided guidance for the first quarter of 2023. Fourth-quarter

McCormick (MKC) expects to drive sales growth in 2023 through pricing actions and cost savings

Shares of McCormick & Company Inc. (NYSE: MKC) were down over 5% on Thursday after the company missed expectations on its fourth quarter 2022 results and provided a lower-than-expected earnings

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top